🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if taking a sulforaphane nutraceu...
Status
Completed
Location
Sheppart Pratt Health System
Start Date
2017-02-22
Trial ID
NCT02810964
Treatments Being Tested
This study will determine the cardiovascular effects of energy drink consum...
Status
Terminated
Location
David Grant Medical Center
Start Date
2017-06-26
Trial ID
NCT03021616
Treatments Being Tested
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
ING111762 is a 48 week, randomized, double-blind, active-controlled, multic...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-26
Trial ID
NCT01231516
Treatments Being Tested
The purpose of this study is to assess the pharmacokinetics (ie, how the bo...
Status
Completed
Location
Multiple Locations
Start Date
2007-06-14
Trial ID
NCT01756404
Treatments Being Tested
The objective is to determine the safety and immunogenicity of two differen...
Status
Completed
Location
Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP)
Start Date
2020-11-05
Trial ID
NCT04691947
Treatments Being Tested
The goal of this clinical trial is to learn if a new drug that might help p...
Status
Recruiting
Location
Vseobecna fakultni nemocnice v Praze
Start Date
2023-09-07
Trial ID
NCT06047171
Treatments Being Tested
This phase 1/2, multicenter, randomized, double-blind, placebo-controlled t...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00626704
Treatments Being Tested
The purpose of this 52-week study is to evaluate the long-term safety (in t...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-01-01
Trial ID
NCT01316887
Treatments Being Tested